ASCL1 and small cell lung carcinoma: Induced by LSD1 inhibitor treatment while ASCL1 is repressed, we hypothesized that LSD1 repression of ZFP36L1 is required to sustain ASCL1 and SCLC neuroendocrine differentiation.